Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy

Completed · Not applicable

Conditions studied: Kidney Cancer

In brief

The goal of this clinical research is to learn how effective an ultrasound contrast agent, called DEFINITY, is when used during ultrasound-guided surgery to remove part of one or both kidneys.

Key facts

Study ID

NCT01894607

Run by

M.D. Anderson Cancer Center

People needed

11

Starts

2013-10-01

Last updated by the study team

2016-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have previous cross sectional imaging (CT or MRI) demonstrating renal mass or masses that is amenable to open partial nephrectomy.
• Patient is scheduled for intraoperative ultrasound guided open partial nephrectomy.
• Patient must sign informed consent, with risks and benefits of CEUS explained (see risks outlined on the following pages)

You may not qualify if…

• Patients with known renal mass scheduled for total or laparoscopic partial nephrectomy.
• Patients who are hypersensitive to Definity (Perflutren Lipid Microsphere)
• Patients with known history of right-to-left, bidirectional or transient right-to-left cardiac shunts.
• Pediatric patients less than 18 years of age.
• Pregnant or nursing mothers.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.